Patents by Inventor MATHIEU COINÇON

MATHIEU COINÇON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigenic epitopes from EBV gp350/220 and uses thereof
    Patent number: 10016494
    Abstract: The present invention relates to a peptide comprising (A) (i) a first domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence PDDRTLQ (SEQ ID NO:1); and (ii) a second domain covalently linked to the first domain and comprising an amino acid sequence having at least 60% sequence similarity with the sequence QNPVYLIPETVPYIKWDN (SEQ ID NO:2) or (B) (i) a first domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence GSAKPGNGSYF (SEQ ID NO: 41); and (ii) a second domain covalently linked to the first domain, said second domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence SVKTEMLGNEID (SEQ ID NO: 42), wherein the peptide binds to monoclonal antibody clone 72A1.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: July 10, 2018
    Assignees: VALORISATION-HSJ, LIMITED PARTNERSHIP, VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
    Inventors: Caroline Alfieri, Jerome Tanner, Jing Hu, Jurgen Sygusch, Mathieu Coinçon
  • ANTIGENIC EPITOPES FROM EBV gp350/220 AND USES THEREOF
    Publication number: 20170189517
    Abstract: The present invention relates to a peptide comprising (A) (i) a first domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence PDDRTLQ (SEQ ID NO:1); and (ii) a second domain covalently linked to the first domain and comprising an amino acid sequence having at least 60% sequence similarity with the sequence QNPVYLIPETVPYIKWDN (SEQ ID NO:2) or (B) (i) a first domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence GSAKPGNGSYF (SEQ ID NO: 41); and (ii) a second domain covalently linked to the first domain, said second domain comprising an amino acid sequence having at least 60% sequence similarity with the sequence SVKTEMLGNEID (SEQ ID NO: 42), wherein the peptide binds to monoclonal antibody clone 72A1.
    Type: Application
    Filed: February 6, 2015
    Publication date: July 6, 2017
    Inventors: CAROLINE ALFIERI, JEROME TANNER, JING HU, JURGEN SYGUSCH, MATHIEU COINÇON